
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Pfizer Inc
Deal Size : $1,549.0 million
Deal Type : Collaboration
TRIANA and Pfizer Partner to Discover Novel Molecular Glue Degraders
Details : The collaboration aims to discover novel molecular glue degraders for multiple targets in several disease areas, including oncology.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : $49.0 million
October 15, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Pfizer Inc
Deal Size : $1,549.0 million
Deal Type : Collaboration
